Shield Therapeutics plc, announces that the following documents have been sent to shareholders:
· Annual Report and Accounts for the year ended 31 December 2018
· Notice of Annual General Meeting (“AGM”) 2019
In accordance with AIM Rule 26, these documents are available to view here.
The AGM is scheduled to be held at 10.00am BST on Thursday 13 June 2019 at the offices of Stephenson Harwood LLP, 1 Finsbury Circus, London, EC2M 7SH.Back to news